Bringing Medication into Indonesia for a Long Stay

Can You Bring Medication to Indonesia for a Long Stay?

A traveller moving to Bali for six months may have been prescribed medicine every day of that stay. Buying six months' worth before departure sounds sensible until the import rules enter the picture. Indonesia permits medicines for personal use, but the quantity you may carry depends on the product and its legal classification. The length of your residence permit does not increase the allowance.

Two authorities are involved. BPOM, Indonesia's food and drug regulator, sets the rules for personal medicines; Customs, known as Bea Cukai, handles the arrival declaration and baggage checks. An English prescription helps with eligible medication, but it cannot make a prohibited substance lawful.

Treat the journey as two separate arrangements: an admissible supply for arrival and a confirmed way to continue care after that supply runs out. These are Indonesian national rules, not a special set of Bali regulations.

Which Substances Need Extra Checking Before Departure?

A product being a routine prescription at home says little about how Indonesia will treat it at the border. Customs decisions can turn on the actual ingredients, while brand names and descriptions such as “sleep aid” are often ambiguous. Even two medicines prescribed for the same condition may fall into different legal categories.

Ordinary, non-controlled medicines are assessed by dosage form and quantity. Tablets and capsules have a different no-prescription threshold from drops, creams and inhalers. Carrying more than the relevant threshold calls for medical documentation and a treatment-based calculation; it does not create an exemption for a restricted ingredient.

Psychotropic and narcotic classifications need particular care. Indonesia's schedules, not the diagnosis or the product's status in the country of purchase, determine whether special rules or a prohibition apply. A combination medicine can contain several active ingredients, including one that changes how the entire product is treated. The same problem arises when familiar brands have different formulations across countries.

The useful starting record is the generic ingredient name, strength, formulation and prescribed use of each medicine. BPOM can be asked for a substance-specific clarification when those details do not produce a clear answer. Vitamins, herbal preparations and dietary supplements should also be considered separately: they are not automatically covered by the personal-medicine limits discussed here.

How Many Tablets or Packages Can You Carry?

BPOM's guidance, current as of 23 October 2026, measures small amounts of medicine carried in passenger baggage by dosage form. Without a prescription, the stated threshold for solid medicines is 30 individual tablets or capsules of each product type. Creams, gels, liquids and aerosols have a threshold of three product units. Thirty tablets does not mean thirty boxes or thirty blister strips.

For an eligible product above that threshold, an English-language prescription is required. The permitted quantity must match the prescribed treatment and cannot exceed a 90-day supply. That is a duration of treatment, not a universal pill count. Neither a long-stay visa nor a larger suitcase changes the calculation.

Consider a medicine prescribed at two capsules per day. Ninety days requires 180 capsules, calculated as 2 × 90. That may fit the ordinary prescription-based allowance if the ingredient is permitted and the medical document supports that exact regimen. Packing 360 capsules for a six-month stay would exceed that ordinary limit. A different prescription, such as one tablet daily, produces a different 90-day quantity.

This is not the calculation for every controlled drug. Eligible psychotropic medicines have a separate limit of up to 60 days under specific conditions; narcotic medicines cannot be imported under BPOM's personal-use guidance. Ingredient classification therefore needs to be settled before the supply is counted.

What Documents Should Accompany Your Prescription?

A prescription matters because Customs may need to establish why a traveller is carrying a particular drug and quantity. A document showing only a brand name and the phrase “as directed” leaves the most relevant questions unanswered. The paperwork should link a known ingredient and daily regimen to the supply actually in the bag.

Ask the prescribing clinician for an English-language prescription or supporting medical letter. The patient's full name should match their passport and travel documents. Include the generic name of every active ingredient, strength, dose per administration, daily frequency, intended treatment period and total quantity. Combination products deserve the same level of detail for all their ingredients. If you are carrying medicine for a child or another family member, the documentation should identify that patient.

BPOM describes the relevant prescription as one issued by a clinician providing care in the country the medicine comes from. The medical order needs to come from the clinician, not be reconstructed by the traveller for the airport. A short explanation of personal medical use can be helpful when the quantity is large. Consistency matters: the stated daily dose should account for the number of tablets, bottles or inhalers being carried.

Keep each product in its original labelled packaging. This gives officers a way to match the prescribed ingredient and strength to a recognisable product. Loose tablets in an unmarked organiser can make an otherwise straightforward check much harder. A digital scan is useful as backup, although carrying the original medical document remains the more dependable approach.

Indonesian consular guidance says that the doctor's letter does not need embassy legalisation. It does not guarantee admission: Indonesian Customs retains authority to review medicines and their documentation. Even where the small-quantity rule does not require a prescription, a clear medical letter is sensible for medicine someone relies on continuously.

What Are the Rules for Psychotropic and Narcotic Medicines?

Controlled medicines are where a familiar prescription can create a false sense of security. A drug may be routinely prescribed in one country and still be restricted or prohibited on entry to Indonesia. BPOM applies different rules to legally classified psychotropic and narcotic substances; neither category is covered by the general 90-day prescription allowance.

For certain psychotropic medicines, direct carriage in passenger baggage is permitted only for foreign nationals. The traveller must have an English prescription, and the amount cannot exceed 60 days of prescribed treatment. BPOM identifies Indonesian psychotropic Categories II, III and IV as categories that may be used medically. Eligibility is still substance-specific; the category of a particular ingredient has to be established before treating that allowance as applicable.

BPOM's published personal-import guidance prohibits bringing narcotic medicines into Indonesia from abroad, even for an individual's treatment. A prescription does not remove the restriction. Mailing the product is not permitted either. Foreign brand labels and broad descriptions such as “painkiller” do not establish whether the active ingredient is legally classified as a narcotic.

This matters to travellers taking medication for anxiety, ADHD, sleep disorders or severe pain, but no diagnosis reliably predicts the customs answer. The safest point at which to resolve uncertainty is before tickets and medicine supplies are finalised. An enquiry to BPOM should identify the generic ingredients, strength, formulation and intended amount; a written, substance-specific response is more meaningful than a traveller's anecdote or a pharmacy's verbal reassurance.

If a medicine cannot legally accompany the traveller, the treating clinician needs to assess what continued care is feasible in Indonesia. A different prescription, treatment setting or destination may have to be considered. Do not stop, substitute or ration an essential medicine on your own to make an itinerary work.

How Do You Declare Medication on Arrival in Indonesia?

International air arrivals, including flights into Bali, use the All Indonesia arrival system. Its single submission includes the Customs declaration along with other entry information. Bea Cukai says travellers can complete it from three days before arrival and retain the resulting QR confirmation. The older standalone electronic customs form is not the current route for this type of arrival.

Medication should be declared accurately in the customs part of the form. Travellers with prescriptions or potentially controlled ingredients have particular reason to be precise, although the questions on screen may change over time. Look for the current prompts about medicines and restricted goods. Passing through a green channel does not grant an exemption from BPOM requirements.

At the airport, Customs can ask to inspect medicines, verify packaging and compare quantities with the prescription. An unclear ingredient or excessive supply may lead to further checks, potentially involving BPOM. Having the original containers and the medical documents close at hand makes the substance and treatment calculation easier to establish.

BPOM's Special Access Scheme guidance generally does not require a separate import permit for compliant personal medicines. That is a limited exemption from an import-permit process, not an exemption from declarations or ingredient restrictions. Officers may refuse entry to products that fail the applicable requirements.

Can You Mail Medication to Indonesia Instead?

An overseas parcel is treated differently from medication in a passenger's luggage. Under BPOM's personal-import guidance, eligible medicines sent by post or courier require a doctor's prescription and are limited to a treatment supply of no more than 90 days. The small-quantity rule allowing 30 tablets or three product units without a prescription applies to passenger baggage, not parcels.

The distinction is especially sharp for controlled substances. Psychotropic medication may be eligible for direct carriage by a foreign national under special conditions, yet it cannot be shipped from overseas. Narcotic medicines are prohibited through both channels. Describing a package as a personal gift or sending it to a residential address does not change those restrictions.

A plan to fly in with an initial supply and have relatives mail the rest is therefore not a dependable default for a long stay. Even an ordinary prescription medicine needs to meet the parcel rules and any applicable carrier requirements. Customs still assesses the consignment; a delivery booking is not evidence that the medicine can lawfully enter Indonesia.

How Should You Continue Treatment After 90 Days in Bali?

For someone on lifelong medication, the end of the import allowance is not the end of the prescription. The critical planning question is whether treatment can continue without an unsafe gap. Before leaving, the treating clinician should help establish what ongoing care is required and what to do if a Bali appointment or medicine supply is delayed. Stretching doses to cover a longer stay is not a sound contingency plan.

BPOM's product register is a useful first filter. Search by the medicine's name and then, where necessary, by its active ingredient. Compare the registered result with the actual strength and dosage form prescribed. A product with a similar brand name may not be equivalent. More importantly, being listed in the national register does not prove that a pharmacy on Bali has stock.

Availability needs a separate check with a licensed local pharmacy or healthcare provider. A clinician in Indonesia can then assess continuation of care, local prescription requirements and appropriate monitoring. An overseas prescription may explain treatment history, but it is not a guarantee that the exact medicine will be dispensed locally. Stock and distribution can change, even for registered products.

Refrigerated or otherwise temperature-sensitive medication adds another layer of travel planning. Packaging, airline carriage conditions and storage after arrival should be discussed with the airline and the clinician, based on the individual product. If the medicine is not registered or cannot be located, do not assume that arranging another private import will solve the problem.

There are situations in which postponing the move is the safer outcome. A clinician may also be able to help assess treatment options in another destination. Decisions about doses, discontinuation or substitution require medical advice; the import rules must be rechecked with BPOM and Customs for the actual travel date.